Key Highlights
- Addus HomeCare shares are indicated down 5.82% in pre-market trading at $109.99, despite the company beating second-quarter estimates.
- Second-quarter net service revenues rose 8.0% year over year to $377.4 million, with adjusted EPS of $1.73, up 16.1% year over year.
- Adjusted EBITDA increased 11.9% to $49.2 million, with hospice organic revenue growth of 11.1% highlighting continued strength in that segment.
- Shares closed up 1.13% during Monday's regular session ahead of the report but slid roughly 4% in after-hours trading once results were released.
- The pullback echoes a similar 'sell-the-news' pattern seen at peer BrightSpring Health Services, which fell sharply after its own strong Q2 beat-and-raise report.
What's Driving the Pre-Market Move
Addus HomeCare (NASDAQ:ADUS) shares are indicated down 5.82% in pre-market trading at $109.99, despite the company reporting second-quarter results that beat consensus estimates on both revenue and earnings. The stock had closed up 1.13% during Monday's regular session ahead of the report, but slid roughly 4% in after-hours trading once results were released.
Addus HomeCare is a Frisco, Texas-based provider of in-home care services, founded in 1979, that serves approximately 62,500 consumers across 264 locations in 24 states. The company operates through three segments: Personal Care, representing roughly 75% of revenue, Hospice, representing roughly 20%, and Home Health, representing roughly 6%, primarily assisting elderly, chronically ill, and disabled individuals who are at risk of hospitalization or institutionalization.
Second-quarter net service revenues were $377.4 million, up 8.0% from $349.4 million in the second quarter of 2025, modestly ahead of consensus of $376.2 million. Adjusted net income per diluted share was $1.73, compared with $1.49 in the prior-year period, also modestly ahead of the $1.70 estimate. Adjusted EBITDA increased 11.9% year over year to $49.2 million from $43.9 million, with net income up 25.2% to $27.6 million.
Personal care revenue grew 6.8% organically, accounting for 78.4% of total revenue, reflecting higher volumes and two months of contribution from HomeCourt Home Care, acquired May 1, alongside rate increases implemented in Texas and Illinois. Hospice revenue growth of 11.1% highlighted continued strength in that segment, driven by improvements in average daily census and revenue per patient day, while home health revenue represented 4.6% of the quarter's total, with management citing more favorable admission and volume trends.
A Broader Sector Pattern
Despite the in-line-to-slight-beat quarter, the after-hours pullback suggests investors may be reacting to valuation concerns or softer forward commentary, echoing a similar sell-the-news pattern seen at peer BrightSpring Health Services (NASDAQ:BTSG), which fell sharply after its own strong second-quarter beat-and-raise report days earlier amid a broader home health and hospice sector re-rating.
As of June 30, Addus had cash of $99.6 million and bank debt of $64.3 million, with $577.8 million of availability under its revolving credit facility. Net cash provided by operating activities was $40.0 million for the quarter. Chairman and CEO Dirk Allison highlighted the company's low leverage as providing flexibility to pursue targeted acquisitions and enhance market density, with management citing continued demand for cost-effective home-based care services.
Addus HomeCare's market capitalization stood at $2.18 billion at Monday's close, with a forward price-to-earnings ratio of 13.74. The stock's 52-week range spans $87.95 to $124.44.
Conclusion
Addus HomeCare's pre-market decline despite a genuine earnings beat reflects a broader pattern of investor caution across the home health and hospice sector following a recent re-rating, rather than a reaction to negative company-specific results. With hospice growth remaining a bright spot and the company maintaining a strong balance sheet to pursue further acquisitions, the durability of today's pullback will likely depend on how the broader sector narrative evolves in the coming sessions.
This article is for informational purposes only and does not constitute investment advice. Readers should conduct their own research before making financial decisions.






Please wait processing your request...